Medical Device Network on MSN

FDA clears Cepheid’s Xpert GI panel for pathogen detection

The Xpert GI Panel identifies pathogens directly from stool specimens collected in Cary-Blair transport media.
Pharmabiz

Henry Schein to distribute Cepheid's GeneXpert System in US

Cepheid, a leading molecular diagnostics company, announced an agreement with Henry Schein Medical, the US Medical business of Henry Schein, Inc., for the distribution of its GeneXpert System and menu ...
Nasdaq

Cepheid Receives Emergency Use Authorization For SARS-CoV-2, Flu A, Flu B and RSV Combination Test

SUNNYVALE, Calif., Sept. 29, 2020 /PRNewswire/ -- Cepheid today announced it has received Emergency Use Authorization (EUA) from the U.S. Food & Drug Administration (FDA) for Xpert® Xpress ...
CNN

Cepheid Announces Development of Four-in-One Combination Test for SARS-CoV-2, Flu A, Flu B and RSV

SUNNYVALE, Calif., June 9, 2020 /PRNewswire/ -- Cepheid today announced the development of a next-generation test to assist global efforts in the fight against the spread of COVID-19 during the ...
Business Insider

Cepheid Receives Health Canada License for SARS-CoV-2, Flu A, Flu B and RSV Combination Test

Challenged by Similar Clinical Presentations, Accurate Detection & Differentiation of all 4 Viruses is Critical for Clinicians This Flu Season SUNNYVALE, Calif., Jan. 14, 2021 /CNW/ -- Cepheid today ...